The Honest Company - Awaiting More Consistent Improvements

The Honest Company faces stagnating improvements, with shares down 25% over the past year and operating profits still elusive.

Despite organic growth, Honest's top-line sales are declining due to divestitures, and adjusted EBITDA margins have contracted year-over-year.

Guidance for 2026 anticipates further sales declines but expects organic growth and flat adjusted EBITDA, with continued net cash strength.

I remain cautious, awaiting Q2 results for evidence of sustainable margin improvement and consistent organic growth to support a more investable thesis.

It was a year ago when I concluded that shares of The Honest Company (HNST) were finding themselves on a more stable footing.

This followed a remarkable improvement in margins, as regained operating profits